Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New DNA testing scheme for Tibetan terriers
The new scheme tests for pituitary dwarfism in the Tibetan terrier.
Test results will be added to the dog’s registration details.

The Kennel Club has announced a new DNA test reporting scheme for pituitary dwarfism in the Tibetan terrier.

Launched following consultation with the breed’s health coordinator, on behalf of the breed clubs, the results of the test will be recorded with the abbreviation 'DP-LHX3'.

“The Kennel Club constantly reviews DNA testing schemes in conjunction with breed clubs to ensure that breeders are supported with resources which help them to make responsible breeding decisions,” said Dr Joanna Ilska, genetics & research manager at The Kennel Club.

“The Kennel Club works alongside breed clubs and breed health coordinators in a collaborative effort to improve the health of pedigree dogs and is happy to consider a club's request to add a new DNA test to its lists. A formal request from the breed's health coordinator or a majority request from the breed clubs is normally required to do this.”

Pituitary dwarfism is an inherited disease caused by insufficient amounts of growth hormone in the body. Puppies with the condition may not be noticeably different at birth, but their growth will not follow the usual pattern, and they can die at a young age.

Owners of dogs with pituitary dwarfism may notice their dogs are smaller than others of the same breed and that they may remain puppy-like in looks. Affected dogs may retain their soft puppy coat, experience hair loss or have problems with tooth development.

Dogs tested for the condition will be recorded on the Kennel Club systems as one of the following:

Clear

The dog does not have any copies of the abnormal gene associated with the disease. The dog is highly unlikely to be clinically affected and will only pass on a normal copy of the gene to a puppy.

Carrier
The dog has one copy of the normal gene and one copy of the abnormal gene associated with the disease. The dog is highly unlikely to be clinically affected but may pass one copy of the normal gene, or one copy of the abnormal gene onto a puppy.

Affected
The dog has two copies of the abnormal gene associated with the disease. The dog will likely be clinically affected by the disorder and will pass one copy of the abnormal gene to any potential offspring.

More information about which laboratories The Kennel Club can record results from - and which labs will send results direct to The Kennel Club - can be found at : thekennelclub.org.uk/DP-LHX3

Test results will be added to the dog’s registration details which will trigger the publication of the result in the next available Breed Records Supplement. Results will also be added to the Health Test Results Finder on The Kennel Club website. 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.